Feasibility and Success Trial of Remote Patient Monitoring in Heart Failure
- Disease/Condition
- Congestive Heart Failure
- Drug/Device/Intervention
- VitalCare Platform
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Saint Luke's Health System
- Location
- Kansas City,Overland Park,Kansas City,Lee's Summit, United States of America
- Phase
- N/A
- Start date
- Aug 01, 2023
- End date
- Dec 31, 2025
- Enrollment
- 30 participants
Compliance with monitoring protocol
Previous research has investigated the use of remote patient monitoring in various clinical
 contexts, however there has not been a clinical trial examining use of the VitalCare platform
 for ambulatory management of heart failure. This trial will serve as a pilot study examining
 the feasibility of use of the VitalCare platform for ambulatory heart failure management and
 examine the effect of remote patient monitoring on patient engagement. To the investigators'
 knowledge, this will be the first study examining the effect of remote patient monitoring
 with the VitalCare platform on heart failure clinical outcomes, such as hospitalization for
 heart failure exacerbations and emergency room visits for heart failure.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05900362
- Type
- Device Trial
Access comprehensive clinical trial information for NCT05900362 through Pure Global AI's free database. This phase not specified trial is sponsored by Saint Luke's Health System and is currently Not yet recruiting. The study focuses on Congestive Heart Failure. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.